CME: Quality Care in the Delivery Room: Can the Use of Fetal Fibronectin (fFN) Help Meet Quality Standards?

Quality Care in the Delivery Room: Can the Use of Fetal Fibronectin (fFN) Help Meet Quality Standards?

Quality Care in the Delivery Room: Can the Use of Fetal Fibronectin (fFN) Help Meet Quality Standards?
RestartResume
With 1 in 10 infants being born too early, this emerging advancement aims to reduce the medical and personal impacts of preterm birth.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Preterm birth not only causes steep medical costs, but it also has a significant impact on the child and family, resulting in both short-term and long-term complications like neurocognitive delays and growth impairments. This activity will explore the use of fetal fibronectin (fFN) as a marker for women who are at an increased risk of a preterm birth.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Host:
    Jennifer Caudle, DO
    Family Medicine Physician and Assistant Professor
    Department of Family Medicine
    Rowan University-School of Osteopathic Medicine
    Stratford, New Jersey

    Dr. Caudle has no financial relationships to disclose. 

    Faculty:
    Michael G. Ross, MD, MPH
    Distinguished Professor of Obstetrics and Gynecology
    Geffen School of Medicine at UCLA
    Los Angeles, CA

    Dr. Ross has no financial relationships to disclose.

    Michael S. Ruma, MD, MPH
    Maternal-Fetal Medicine
    Perinatal Associates of New Mexico
    Albuquerque, NM

    Dr. Ruma receives consulting fees, is a speaker and conducts contracted research for Hologic, Inc.

    Reviewers/Content Planners/Authors:

    • Kenneth Brown has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Incorporate better appreciation of the prevalence, burden, and consequences of preterm birth into more proactive risk assessment of symptomatic women.
    • Utilize diagnostic tests, such as fetal fibronectin, with or without ultrasonography, when assessing the risk for preterm birth.
    • Recognize the need for systematic processes and use of algorithms to successfully and cost-efficiently risk assess patients for preterm delivery.
  • Target Audience

    This activity is designed to meet the educational needs of Obstetricians, Gynecologists, Maternal Fetal Medicine specialists, Obstetric hospitalists, CNMs, Labor and Delivery nursing staff, and Women's Health Residents.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 credits here AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from Hologic, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Omnia Education newsletters.
Comprehensive women’s health CME.

Better education for a better you.

* Required
Optional
Register

Join Omnia Education's community of women's health professionals.
Registration is free and easy.

Register Now